According to the recent research report titled ‘Global Bariatric Surgery Market 2019-2028’, available with Market Study Report, global bariatric surgery market is projected to expand with a CAGR of 9.41% over 2019-2028.
 

Increasing rate of obesity, and rising prevalence of diabetes and cardiac diseases are fueling global bariatric surgery market growth, cites the study. Numerous government initiatives to improve cognizance about obesity and its ill-effects, in consort with technological advancements are significantly contributing to the market development.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552786/
 

However, high costs related to such surgeries, and lack of awareness among patients are anticipated to hamper the industry expansion. Besides, low and middle-income economies do not have basic access to surgical care due to illiteracy among the population regarding such procedures, which acting as a major challenge.
 

Based on device gamut, the market is split into assisting device (stapling device, trocars, suturing device, closure device, others), implantable device (gastric emptying, electrical stimulation device, gastric band, gastric balloon, others), and others.
 

From regional perspective, Middle East & Africa, Latin America, Asia Pacific, Europe, and North America are the leading contributors to global bariatric surgery market remuneration. Of these, Asia Pacific industry is predicted to witness robust CAGR over 2019-2028, owing to health initiatives taken by government and private organizations in economies like India and China. Strong presence of major contenders in the region is further leading to innovations and research & development activities, facilitating industry expansion.
 

Considering the competitive landscape, ReShape Lifesciences Inc., Medtronic plc, Aspire Bariatrics, Ethicon Inc. (Johnson & Johnson), ConMed Corporation, Lupin Ltd., The Cooper Companies Inc., Intuitive Surgical Inc., Allergan plc, Apollo Endosurgery Inc., GE Healthcare (General Electric Company), B. Braun Melsungen AG, Abbott Laboratories, and Olympus Corporation are the key players impacting global bariatric surgery industry trends.
 

The report casts light on the winning strategies adopted by these industry contenders, along with recent developments such as acquisitions & mergers, product launches, and expansion roadmaps to assist stakeholders formulate action plans that would help enhance their revenue in upcoming years.